on 12 Dec 2023
Last Applicant/ Owned by
CZ-170 00 Prague 7
CZ
Serial Number
79345925 filed on 14th Apr 2022
Registration Number
7238443 registered on 12th Dec 2023
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy mater Read More
Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; product research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies
Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, tcr-t therapy materials, namely, T cell receptor T cell-based pharmaceuticals, or car-nk therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals to the order and specification of others
Packaging services in the nature of applications of labels to cell therapy materials; storage and distribution of cell therapy materials
No 79345925
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
02th Apr 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
13th Mar 2024 | FINAL DISPOSITION PROCESSED |
13th Mar 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
12th Mar 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
16th Feb 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
16th Feb 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
16th Feb 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
12th Dec 2023 | REGISTERED-PRINCIPAL REGISTER |
12th Dec 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
26th Sep 2023 | PUBLISHED FOR OPPOSITION |